trastuzumab,adalimumab,rituximab,epoetin
abbvie
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'adalimumab', 'rituximab', 'epoetin', 'ritux']
75 different biosimilars in europe, and nearly 20 years since the journey started. has led the world on biosimilars #eular2023 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes journal podcast host. All opinions my own